Что думаешь? Оцени!
作为最常见的侏儒症类型，软骨发育不全（ACH）过去很长时间无特效疗法，直到2021年，“孤儿药之王”BioMarin研发的Vosoritide，作为首个获批药物，才开启了药物对症治疗时代。凭借独家优势，其2025年销售额高达9.27亿美元。
。关于这个话题，一键获取谷歌浏览器下载提供了深入分析
07:30, 28 февраля 2026ЭкономикаЭксклюзив
Built on a shared FastConformer encoder (Conv2d 8x subsampling → N Conformer blocks with relative positional attention):
London-based data infrastructure startup Encord has closed a €50 million ($60 million) Series C funding round, led by Wellington Management, with participation from existing backers including Y Combinator, CRV, N47, Crane Venture Partners and Harpoon Ventures, alongside new investors Bright Pixel Capital and Isomer Capital. The round brings total capital raised to about €93 million […]